This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Compare fund families based on index fund history and identify which has demonstrated the strongest long-term performance and stability.
28,115 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Strategy unveiled a broad capital-management package to steady its Bitcoin-buying strategy, but analysts say the next...
The retirement myth of needing a million dollars is fading. Income-focused strategies and Social Security can cover a...
Investors are weighing whether UTES's AI-driven utility tilt justifies a roughly 0.50% fee as 2026 market conditions ...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
A leading home improvement stock fell 40% last quarter as growth cooled, triggering a $14 million trimming of a major...
Newmont Corporation stock dropped today as macro data and gold price moves rattled investors. This guide explains the...
A veteran financial journalist breaks down abacus global (abx) 2025 Q4 results, explains what the numbers mean for 20...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
When a legendary investor signals confidence, investors listen. This article delves into why this unstoppable stock s...